Associazione Italiana per la Ricerca sul Cancro   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Milan Italy (1965)

Organization Overview

First Clinical Trial
1998
NCT00273247
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Associazione Italiana per la Ricerca sul Cancro

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma in Situ (Phase 3)

Fibroma (Phase 2)

Fibromatosis, Aggressive (Phase 2)

Fibrosis (Phase 3)

Graft vs Host Disease (Phase 2)

Hepatitis C (Phase 3)

Leukemia (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Liver Cirrhosis (Phase 3)

Triple Negative Breast Neoplasms (Phase 2)

Virus Diseases (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 9
  • # of Trial APIs: 10